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A B S T R A C T
Objective: To investigate whether Escherichia coli bacteriuria is associated with the development of
hypertension during a long-term follow-up.
Methods: A prospective cohort study was performed among the participants of two population-based
studies. Between 1974 and 1986 all women aged 39 to 68 years old, who lived in Utrecht, the
Netherlands, were invited to participate in a breast cancer screening program. The participants
completed a questionnaire, underwent a medical examination, and collected a morning urine sample
that remained stored. From 1993 to 1997 another population-based study was performed. We
performed a full cohort analysis for 444 women who participated in both studies. E. coli bacteriuria was
diagnosed by a real-time PCR. Hypertension was deﬁned as the use of antihypertensive medication and/
or a measured systolic blood pressure of at least 160 mmHg or a diastolic blood pressure of 95 mmHg or
higher. The mean follow-up was 11.5  1.7 years.
Results: Fortywomen (9%) had E. coli bacteriuria at baseline.Womenwho had bacteriuria at baseline had
a mean blood pressure at study endpoint of 133  20 mmHg systolic and 78  11 mmHg diastolic, and
women without bacteriuria had values of 129  20 and 78  11 mmHg, respectively (p-values for difference
0.33 and 0.88). Although E. coli bacteriuria was not associated with the blood pressure as a continuous
variable, it was associated with the development of hypertension during follow-up (OR 2.8, 95% CI 1.4–5.5).
Conclusion: E. coli bacteriuria may increase the risk of future hypertension.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Although the urinary tract is normally sterile, asymptomatic
bacteriuria is a common phenomenon, especially in women.
Different studies report a prevalence of asymptomatic bacteriuria
of approximately 5% among healthy young women, increasing to
over 20% in the elderly.1,2 Escherichia coli is the most prevalent
uropathogen.3 Several authors in the ﬁrst half of the twentieth
century have suggested a role of bacteriuria in the etiology of
hypertension.4 Although more recent studies have also found a
correlation, no prospective study has convincingly shown that
bacteriuria itself leads to hypertension.5
The present study aimed to address the question of whether or
not E. coli bacteriuria is associated with an increased risk of the
development of hypertension during a long-term follow-up period.* Corresponding author. Tel.: +31 88 7555555; fax: +31 88 7555533.
E-mail address: r.meiland@umcutrecht.nl (R. Meiland).
1201-9712/$36.00 – see front matter  2009 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.05.015In addition, the risk of a heart attack or stroke in the presence of
bacteriuria was studied.
2. Methods
2.1. Study population
A full cohort analysis was performed for women who
participated in two population-based studies. Between 1974 and
1986, all women born between 1911 and 1945, who lived in the
city of Utrecht and surrounding area, were invited for a breast
cancer screening program, with a participation rate of 68–72%.6 A
total number of 38 994 women aged 39 to 68 years at intake
participated (the baseline cohort). Baseline measurements, per-
formed between 1974 and 1986, included extensive question-
naires, a short medical examination, and the collection of a
midstream morning urine sample. Data obtained through the
questionnaires included age,marital status, smoking habits, parity,
menopausal age, diet, and drug use. During the medical examina-
tion weight and height were measured. Approximately 200 mlses. Published by Elsevier Ltd. All rights reserved.
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agents, and stored at 20 8C for future analyses.7 All women gave
oral consent to use their data and urine samples for future
scientiﬁc research.
From 1993 to 1997, participants in the breast cancer screening
program received an invitation by mail to join an additional study
to assess the relationship between nutrition and cancer and other
chronic diseases, the Prospect-EPIC study (the follow-up cohort). A
total of 17 357 women living in Utrecht and the surrounding area
agreed to take part (participation rate 34.5%).8 Participants were
between 49 and 70 years of age at enrolment. Information was
collected on the basis of two self-administered questionnaires and
a medical examination including blood pressure. Non-fasting
blood samples were successfully drawn from 97.5% of the women
and stored under liquid nitrogen at 196 8C. The serum creatinine
level was later measured from these samples. Approximately 88%
of the women signed a detailed informed consent, enabling the
researchers to use their blood samples for future analysis, and to
obtain information on future morbidity and mortality.8
In total, 506 women participated in both the baseline cohort and
the follow-up cohort. Sixty-two women had to be excluded for the
following reasons: a missing urine sample (n = 13), the use of
antihypertensive medication at baseline (n = 45), kidney transplan-
tation during follow-up (n = 1), or missing data on hypertension at
study endpoint (n = 3). Finally, 444 women were included in the
prospective study toassess the relationshipbetweenbacteriuria and
the development of hypertension. The mean duration of follow-up
was 11.5  1.7 years, ranging from8.3 to18.6 years frombaseline until
participation in the follow-up study (and was not different for women
with compared to women without bacteriuria).
This study was approved by the Medical Ethics Committee of
the University Medical Center Utrecht, the Netherlands.
2.2. Escherichia coli bacteriuria
E. coli bacteriuria was deﬁned as the presence of 105 colony
forming units (cfu) of E. coli per ml of urine. It was diagnosed by a
real-time PCR that we developed and validated beforehand, a
technique that has also been used by others.9,10 Brieﬂy, PCR
primers and probe complementary to regions of the gadA gene
speciﬁc for E. coli were designed for the real-time PCR assay. The
laboratory sensitivity and speciﬁcity of the real-time PCR tested
with 50 E. coli strains and with 41 non-E. coli strains (including the
most prevalent uropathogens and many members of the vaginal
and anal ﬂora) were 100% (50/50) and 98% (40/41), respectively.
For clinical evaluation, 42 clinical urine specimens (12 with and 30
without E. coli) were tested and the results were compared to those
of a clinical conventional urine culture. The sensitivity and
speciﬁcity of the real-time PCR in these clinical samples were
92% and 87%, respectively. The test results were quantitative and
allowed distinguishing between signiﬁcant bacteriuria (i.e., 105
cfu/ml) and low-count bacteriuria that might have been due to
contamination.Table 1
Baseline characteristics for the total cohort study, and separately for women with vers
Total study group (N = 444)a
Age, years 44.9  3.2
Body mass index, kg/m2 24.0  3.2
Postmenopausal 98 (22%)
Married or living with partner (N = 336) 303 (90%)
Given birth to living child(ren) 401 (90%)
Antibiotics (N = 108) 13 (12%)
Values are given as mean  standard deviation or as number of patients (percentage).
a The total number of study subjects is 447 unless otherwise stated.To test a study urine sample, 1 ml of urine was centrifuged at
16 250  g for 5 min. The pellet was washed twice, suspended in
1 ml of sterile injection water, and 100 ml of the suspension was
heated for 2 min at 1000 Watt in a microwave oven for DNA
preparation. Five microliters was added to the real-time PCR
reaction volume as DNA template. Each 25ml reaction volume
consisted of 12.5 ml 2  TaqMan Universal PCR Master Mix
(Applied Biosystems, Branchburg, New Jersey, USA) that contains
AmpliTaq Gold DNA polymerase, 300 nM forward primer (50-
ACCGACATCGTGGTGATGC-30), 300 nM reverse primer (50-AGCAA-
CAGTTCAGCAAAGTCCA-30), and 175 nM probe (50-CAT-
TATGTGTCGTCGCGGCTTCGAA-30); the DNA template was the
last ingredient added. The ABI PRISM 7700 Sequence Detection
System (PE Biosystems, Nieuwerkerk aan de IJssel, the Nether-
lands) was used for the real-time PCRs. Cycling parameters were
ﬁrst the uracil-N-glycosylase (UNG) reaction at 50 8C for 2 min,
then AmpliTaq Gold activation at 95 8C for 10 min, followed by 45
cycles of denaturation at 95 8C for 15 s – combined annealing and
extension at 60 8C for 1 min. Emitted ﬂuorescence from each well
was measured during both the denaturation and annealing/
extension steps in every cycle. Ampliﬁcation plots were con-
structed using the ABI PRISM 7700 Sequence Detection System
software, version 1.7 (PE Biosystems).
2.3. Blood pressure, heart attack, stroke
Blood pressure was measured with a standard mercury
sphygmomanometer after the subject had been seated for
5 min. Hypertension was deﬁned as the previous use of
antihypertensive medication (assessed at follow-up by the
question: ‘‘Have you ever been treated with drugs for high blood
pressure?’’) and/or a measured systolic blood pressure of at least
160mmHg or a diastolic blood pressure of 95mmHg or higher.11 A
history of having had a heart attack or stroke was assessed at
follow-up by the two additional questions: ‘‘Have you ever had a
heart attack?’’, ‘‘Have you ever had a stroke?’’.
2.4. Data analysis
The present results are based on a cohort study of 444 women
who were followed for the development of hypertension in
relation to E. coli bacteriuria at baseline.
Baseline characteristics were compared between women with
and without bacteriuria. Comparisons between means were
performed with the Student’s t-test and comparisons between
nominal or categorical data with the Chi-square test. Linear
regression analysis was used to calculate the adjusted difference in
blood pressure between women with versus women without
bacteriuria. The relative risk of hypertension in the presence of
bacteriuria was estimated by logistic regression and quantiﬁed as
odds ratios (OR) and 95% conﬁdence intervals (CI). Adjustmentwas
done for potential confounding factors, i.e., age, weight, and serum
creatinine level.us without E. coli bacteriuria at baseline.
No E. coli bacteriuria (n = 404) E. coli bacteriuria (n = 40) p-Value
44.9  3.2 45.3  3.4 0.51
23.9  3.2 24.6  3.6 0.26
88 (22%) 10 (25%) 0.64
273 (90%) 30 (97%) 0.20
363 (90%) 38 (95%) 0.29
10 (10%) 3 (33%) 0.04
Table 2
Follow-up characteristics of the cohort study divided into women with and without E. coli bacteriuria (N = 444 unless otherwise stated).
No E. coli bacteriuria (n = 404) E. coli bacteriuria (n = 40) OR (95% CI) p-Value Adjusted p-valuea
Hypertensionb 78 (19%) 16 (40%) 2.8 (1.4–5.5) 0.003 0.003
Antihypertensive medication 49 (12%) 10 (25%) 2.4 (1.1–5.2) 0.03 0.03
Systolic BP 160 and/or diastolic BP 95 mmHg 45 (11%) 9 (23%) 2.3 (1.0–5.2) 0.04 0.04
Systolic BP > 140 and/or diastolic BP > 90 mmHg 112 (28%) 14 (35%) 1.4 (0.7–2.8) 0.33 0.40
Heart attack ever (N = 443) 4 (1%) 1 (3%) 2.6 (0.3–23.5) 0.41 0.59
Stroke ever 7 (2%) 1 (3%) 1.5 (0.2–12.1) 0.73 0.72
OR, odds ratio; CI, conﬁdence interval; BP, blood pressure.
Values are given as mean  standard deviation or as number of patients (percentage).
a Adjustments were made for age, weight, and serum creatinine.
b For deﬁnition see Methods section.
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Baseline characteristics of the total study group (444 women)
are presented in Table 1, as well as the comparisons between
women with (n = 40, 9%) and without (n = 404, 91%) E. coli
bacteriuria at baseline. The use of antibiotics was the only factor
that signiﬁcantly differed between women with and without
bacteriuria (33% vs. 10%, p = 0.04). Eight of the 45 women (18%)
who had to be excluded because of the use of antihypertensive
medication at baseline had E. coli bacteriuria, which was higher
than the percentage of 9% of the ﬁnal study group without
antihypertensive drugs at baseline (p = 0.06).
At measurement after a mean follow-up of 11.5 years, women
who had E. coli bacteriuria at baseline had amean blood pressure at
study endpoint of 133  20 mmHg systolic and 78  11 mmHg
diastolic, and women without bacteriuria had values of 129  20 and
78  11 mmHg, respectively (p-value for difference 0.33 and 0.88).
Although E. coli bacteriuria was not associated with the blood
pressure as a continuous variable, it was associated with the
development of hypertension (OR 2.8, 95% CI 1.4–5.5) (Table 2). This
was mainly due to more bacteriuric women who started antihy-
pertensive drugswhen compared to non-bacteriuric participants. The
association remained statistically signiﬁcant after correction for age,
weight, and creatinine (OR 2.8, 95% CI 1.4–5.6).
In a subgroup analysis of the 108 women for whom it was
known whether or not they had used antibiotics at baseline, the
same trend was visible, also after correction for antibiotic use,
although it lost statistical signiﬁcance (data not shown). E. coli
bacteriuria was not associated with the different classes of anti-
hypertensive drugs (data not shown). The incidence of heart
attacks and strokes was not increased among women with
bacteriuria at baseline (Table 2).
4. Discussion
In this prospective cohort study, in a population of healthy adult
women, we found a correlation between E. coli bacteriuria and the
prevalence of hypertension 12 years later.
Among the strengths of our study are its size and the length of
follow-up. A ﬁnal cohort of 444 women for whom a urine sample
was stored at baseline could be followed for as long as 12 years,
which gave us the unique opportunity to study bacteriuria and its
long-term consequences.
The limitations include the fact that we had to rely on only one
urine sample to deﬁne bacteriuria. However we, and others, have
validated this before.12 We made the assumption that however
bacteriuria might be transient in a proportion of the bacteriuric
study subjects, bacteriuria at one point reﬂects a higher suscept-
ibility to recurrent and persistent bacteriuria in general, even after
antimicrobial therapy. Previous ﬁndings are supportive of this
assumption.1,13 Some of the urine samples may have become
contaminated before storage, however this will be equally dividedin the total study group. Moreover, contamination usually leads to
the growth of more pathogens, often non-E. coli, with lower colony
counts, which are not picked up by our real-time PCR. E. coli is the
causative microorganism found to be most prevalent, and the
prevalence of E. coli bacteriuria of 9% among middle-aged women
reported here is in the range of what could be expected
beforehand. There are no published data that can be cited to
support the test characteristics of real-time PCR on urine stored for
more than 10 years. However, it seems plausible that the gadA gene
for E. coli should still be present also after a long time period. We
did test urine samples that were stored for up to 5 years and
compared the results to those of the conventional urine culture
that was performed at the time the samples were fresh
(unpublished data). The results were similar to those from the
fresh samples. The baseline data included the use of any drugs,
which allowed us to exclude women who used antihypertensive
medication. However, blood pressure was not measured at
baseline, and therefore the study cohort will include some women
with undiagnosed hypertension. At follow-up we had to rely on a
single blood pressure measurement. But we assume that the
incidence of increased blood pressure due to other reasons will be
equally divided among women with and without bacteriuria at
baseline. Moreover, the increased prevalence of hypertension in
the group of bacteriuria was mainly due to more women who
started antihypertensive drugs in this group compared to the
group of women without bacteriuria. Unfortunately, data on the
prevalence of diabetes mellitus at baseline were lacking, and
therefore adjustment for diabetes was not performed.
Several authors in the ﬁrst half of the twentieth century have
suggested a role of bacteriuria in the etiology of hypertension, as
reviewed before.4 For instance, Kass showed small differences in
blood pressure between bacteriuric and non-bacteriuric women
aged 15 to 64 years.14 Althoughmore recent studies have also found
a correlation, no prospective study has convincingly shown that
bacteriuria itself leads to hypertension.5 In our cohort study, we
found a higher prevalence of hypertension in the bacteriuric group
after 12 years of follow-up. The underlying mechanism of this
ﬁnding is not clear. Hypertension is a lasting increase in blood
pressure with a heterogeneous etiology consisting of both genetic
and environmental factors. Patients share the inability to excrete
sodium at a normal arterial pressure.15 If bacteriuria leads to
hypertension, the most attractive explanation would be that
hypertension arises secondary to renal scarring caused by the type
1 ﬁmbriae of the uropathogens. In the multivariate analysis,
correction for creatinine did not change the results, but hyperten-
sion can occur before the reduction in creatinine clearance becomes
apparent (for example in chronic glomerulonephritis).16 The
absence of a change in odds ratio after adjustment for age, weight,
and creatinine conﬁrms the notion that these factors were not
related to bacteriuria. An alternative explanation is that both
bacteriuria and hypertension are found more frequently among
individuals with co-morbidity or that they share a same (currently
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bacteriuria among women who used antihypertensive drugs at
baseline. It remains unclear why E. coli bacteriuria was associated
with the development of hypertension but not with the blood
pressure as a continuous variable. However, it seems plausible that
part of it is due to the success of antihypertensive drugs.
The percentage of women who developed hypertension during
follow-up was in agreement with what could be expected. A large
population-based study performed in the Netherlands also
between 1993 and 1997, showed a prevalence of hypertension
in women in the same age group of 15%.17
In conclusion, in this prospective study a strong correlationwas
found between E. coli bacteriuria and hypertension after 12 years of
follow-up. Given the importance of hypertension the nature of this
correlation needs to be studied further.
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